USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Global Regenerative Medicine Market
Global Regenerative Medicine Market
A New Era in Human Health to Resolve Unmet Medical Needs
RELEASE DATE
05-May-2014
05-May-2014
REGION
North America
North America
Research Code: MA1E-01-00-00-00
SKU: LS00100-NA-MR_16941
$3,950.00
In stock
SKU
LS00100-NA-MR_16941
Description
This research service focuses on the 4 broad segments of the regenerative medicine market, namely cell therapy, gene therapy, tissue engineering, and small molecules and biologics. A detailed overview of the cell therapy segment, including the major commercialised products and products in development, has been provided. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in the global regenerative market have been included. An overview of the other segments—gene therapy, tissue engineering, and small molecules and biologics—has also been provided.
Table of Contents
Executive Summary
Executive Summary (continued)
Regenerative Medicine Market—Game-changing Strategies
Methodology and Scope
Introduction
Introduction (continued)
Introduction (continued)
Market Overview—Segmentation
Market Overview—Cell Therapy (CT)Segment
Market Overview—Cell Therapy (CT)Segment (continued)
Market Overview—Cell Therapy (CT)Segment (continued)
Market Overview—Cell Therapy (CT)Segment (continued)
Market Overview—Gene Therapy (GT) Segment
Market Overview—Tissue Engineering (TE) Segment
Market Overview—Small Molecules and Biologics Segment
Cell Therapy—Competitive Landscape of Marketed Products
Cell Therapy—Competitive Landscape of Products in Development
Cell Therapy—Market Segmentation
Cell Therapy—Marketed Products Synopsis
Cell Therapy—Marketed Products Synopsis (continued)
Cell Therapy—Marketed Products Synopsis (continued)
Cell Therapy—Marketed Products Synopsis (continued)
Product Dashboard—Apligraf (Organogenesis)
Product Dashboard—GINTUIT (Organogenesis)
Product Dashboard—Provenge (Dendreon)
Product Dashboard—Grafix (Osiris Therapeutics)
Product Dashboard—Dermagraft (Shire)
Product Dashboard—Osteocel Plus (NuVasive)
Product Dashboard—ReCell Spray-On Skin (Avita Medical)
Product Dashboard—Trinity Evolution (Orthofix)
Product Dashboard—BioDfactor (BioD, LLC)
Product Dashboard—BioDfence (BioD, LLC)
Cell Therapy—Pipeline Synopsis
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy—Pipeline Synopsis (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued)
Cell Therapy—Pipeline Breakdown
Company—Aastrom Biosciences, Inc.
Company—Advanced Cell Technology, Inc.
Company—Aldagen, Inc. (Acquired by Cytomedix)
Company—Athersys, Inc.
Company—Celgene Cellular Therapeutics
Company—Cellerant Therapeutics, Inc.
Company—Gamida Cell Ltd.
Company—Garnet BioTherapeutics
Company—Histogenics
Company—Mesoblast Ltd.
Company—Neuralstem, Inc.
Company—Osiris Therapeutics, Inc.
Company—Pluristem Therapeutics, Inc.
Company—SanBio, Inc.
Company—StemCells, Inc.
Company—TCA Cellular Therapy, LLC
Company—TiGenix NV
Gene Therapy Overview
Gene Therapy Overview (continued)
Gene Therapy Overview (continued)
Key Company to Watch—Juventas Therapeutics Inc.
Tissue Engineering Overview
Tissue Engineering Overview (continued)
Tissue Engineering Overview (continued)
Tissue Engineering Overview (continued)
Tissue Engineering Overview (continued)
Small Molecules and Biologics Overview
Small Molecules and Biologics Overview (continued)
Cardiovascular Disease (CVD) Regenerative Medicine Market
Cardiovascular Disease (CVD) Regenerative Medicine Market (continued)
Cardiovascular Disease (CVD) Regenerative Medicine Market (continued)
Vascular Disease Regenerative Medicine Market
Vascular Disease Regenerative Medicine Market (continued)
Non-Healing Wounds Regenerative Medicine Market
Non-Healing Wounds Regenerative Medicine Market (continued)
Spinal Cord Injury Regenerative Medicine Market
Spinal Cord Injury Regenerative Medicine Market (continued)
Spinal Cord Injury Regenerative Medicine Market (continued)
Alzheimer’s Disease Regenerative Medicine Market
Alzheimer’s Disease Regenerative Medicine Market (continued)
Parkinson’s Disease (PD) Regenerative Medicine Market
Musculoskeletal Regenerative Medicine Market
Musculoskeletal Regenerative Medicine Market (continued)
Musculoskeletal Regenerative Medicine Market (continued)
Autoimmune Disorders Regenerative Medicine Market
Autoimmune Disorders Regenerative Medicine Market (continued)
Autoimmune Disorders Regenerative Medicine Market (continued)
Stroke Regenerative Medicine Market
Stroke Regenerative Medicine Market (continued)
Diabetes Regenerative Medicine Market
Diabetes Regenerative Medicine Market (continued)
Ocular Diseases Regenerative Medicine Market
Ocular Diseases Regenerative Medicine Market (continued)
Regenerative Medicine Market—Timeline of Key Events
Regenerative Medicine Market—Timeline of Key Events (continued)
Regenerative Medicine Market—Timeline of Key Events (continued)
Regenerative Medicine Market—Timeline of Key Events (continued)
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)
Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)
Regenerative Medicine Market—Funding Scenario
Regenerative Medicine Market—Funding Scenario (continued)
Regenerative Medicine Market—Funding Scenario (continued)
Regenerative Medicine Market—Funding Scenario (continued)
Conclusions and Recommendations
Legal Disclaimer
Human Embryonic Stem Cells Overview
Mesenchymal Stem Cells Overview
Neural Stem Cells Overview
Induced Pluripotent Stem Cells Overview
Stem Cell Types in Development
List of Abbreviations
The Frost & Sullivan Story
Value Proposition
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study covers profiles of late-stage investigational products close to being launched, patent expiration timelines, products in clinical development, launched product profiles, and new product launch timelines.
| No Index | No |
|---|---|
| Podcast | No |
| Author | Aiswariya Chidambaram |
| WIP Number | MA1E-01-00-00-00 |
| Is Prebook | No |